BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 7699466)

  • 41. Regional cerebral blood flow of Alzheimer's disease-like pattern in young patients with Down's syndrome detected by 99Tcm-HMPAO brain SPECT.
    Kao CH; Wang PY; Wang SJ; Chou KT; Hsu CY; Lin WY; Liao SQ; Yeh SH
    Nucl Med Commun; 1993 Jan; 14(1):47-51. PubMed ID: 8423935
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Neuropsychological, psychiatric, and cerebral perfusion correlates of leukoaraiosis in Alzheimer's disease.
    Starkstein SE; Sabe L; Vázquez S; Di Lorenzo G; Martínez A; Petracca G; Tesón A; Chemerinski E; Leiguarda R
    J Neurol Neurosurg Psychiatry; 1997 Jul; 63(1):66-73. PubMed ID: 9221970
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Functional deficits in autistic disorder: characterization by technetium-99m-HMPAO and SPECT.
    Mountz JM; Tolbert LC; Lill DW; Katholi CR; Liu HG
    J Nucl Med; 1995 Jul; 36(7):1156-62. PubMed ID: 7790938
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A method for assessing the significance of abnormalities in HMPO brain SPECT images.
    Houston AS; Kemp PM; Macleod MA
    J Nucl Med; 1994 Feb; 35(2):239-44. PubMed ID: 8294991
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [99mTc-hexamethylpropyleneamine oxime (HMPAO)--its diagnostic potentials for assessing the cerebral blood supply (a review)].
    Krotkov FF; Petunina IV
    Med Radiol (Mosk); 1989 Nov; 34(11):29-35. PubMed ID: 2685504
    [No Abstract]   [Full Text] [Related]  

  • 46. Tc-99m HMPAO brain perfusion SPECT in acute aphasia. Correlation with clinical and structural findings.
    Janicek MJ; Schwartz RB; Carvalho PA; Garada B; Holman BL
    Clin Nucl Med; 1993 Dec; 18(12):1032-8. PubMed ID: 8293621
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Surface and volume three-dimensional displays of Tc-99m HMPAO brain SPECT images in stroke patients by a three-headed gamma camera.
    Shih WJ; Schleenbaker RE; Stipp V; Magoun S; Slevin JT
    Clin Nucl Med; 1993 Nov; 18(11):945-9. PubMed ID: 8269673
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Visual attention deficits in Alzheimer's disease: relationship to HMPAO SPECT cortical hypoperfusion.
    Vasquez BP; Buck BH; Black SE; Leibovitch FS; Lobaugh NJ; Caldwell CB; Behrmann M
    Neuropsychologia; 2011 Jun; 49(7):1741-50. PubMed ID: 21377483
    [TBL] [Abstract][Full Text] [Related]  

  • 49. SPECT in patients with cortical visual loss.
    Silverman IE; Galetta SL; Gray LG; Moster M; Atlas SW; Maurer AH; Alavi A
    J Nucl Med; 1993 Sep; 34(9):1447-51. PubMed ID: 8355062
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Detecting regional cerebral blood flow changes in Alzheimer's patients after milameline treatment: activation or baseline SPECT?
    Zheng XM
    J Nucl Med Technol; 2002 Sep; 30(3):118-22. PubMed ID: 12186960
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Radioanatomy of cerebral perfusion in single-photon emission-computed tomography using 99mTc-labelled amines].
    Liass FM; Kalantarov KD; Kotel'nikova TM; Soboleva OI; Makarevich VS
    Med Radiol (Mosk); 1989 Dec; 34(12):3-7. PubMed ID: 2601589
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The scintigraphic appearance of Alzheimer's disease: a prospective study using technetium-99m-HMPAO SPECT.
    Davis K
    J Nucl Med; 1992 Feb; 33(2):312. PubMed ID: 1732462
    [No Abstract]   [Full Text] [Related]  

  • 53. Comparison of quantitative methods for brain single photon emission computed tomography analysis in head trauma and stroke.
    Loutfi I; Singh A
    Invest Radiol; 1995 Oct; 30(10):588-94. PubMed ID: 8557498
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Neuroanatomical localization for clinical SPECT perfusion brain imaging: a practical proportional grid method.
    Ichise M; Toyama H; Vines DC; Chung DG; Kirsh JC
    Nucl Med Commun; 1992 Dec; 13(12):861-6. PubMed ID: 1465268
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Use of automated image registration to generate mean brain SPECT image of Alzheimer's patients.
    Imran MB; Kawashima R; Awata S; Sato K; Kinomura S; Ito H; Ono S; Yoshioka S; Sato M; Fukuda H
    Ann Nucl Med; 1998 Jun; 12(3):127-32. PubMed ID: 9673712
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Iodine-123-IBZM dopamine D2 receptor and technetium-99m-HMPAO brain perfusion SPECT in the evaluation of patients with and subjects at risk for Huntington's disease.
    Ichise M; Toyama H; Fornazzari L; Ballinger JR; Kirsh JC
    J Nucl Med; 1993 Aug; 34(8):1274-81. PubMed ID: 8326384
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Quantitative assessment of cerebral blood flow in patients with Alzheimer's disease by SPECT.
    Bartenstein P; Minoshima S; Hirsch C; Buch K; Willoch F; Mösch D; Schad D; Schwaiger M; Kurz A
    J Nucl Med; 1997 Jul; 38(7):1095-101. PubMed ID: 9225797
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Basal and activational 99Tcm-HMPAO brain SPECT in Alzheimer's disease.
    Sayit E; Yener G; Capa G; Ertay T; Keskin B; Fadiloglu S; Durak H
    Nucl Med Commun; 2000 Aug; 21(8):763-8. PubMed ID: 11039460
    [TBL] [Abstract][Full Text] [Related]  

  • 59. 99mTc-HMPAO-SPECT in the diagnosis of senile dementia of Alzheimer's type--a study under clinical routine conditions.
    Stoppe G; Staedt J; Kögler A; Schütze R; Kunert HJ; Sandrock D; Munz DL; Emrich D; Rüther E
    J Neural Transm Gen Sect; 1995; 99(1-3):195-211. PubMed ID: 8579805
    [TBL] [Abstract][Full Text] [Related]  

  • 60. SPECT diagnosis of Creutzfeld-Jacob disease.
    Aharon-Peretz J; Peretz A; Hemli JA; Honigman S; Israel O
    J Nucl Med; 1995 Apr; 36(4):616-7. PubMed ID: 7699453
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.